Skip to main content
. 2021 Aug 31;11:661288. doi: 10.3389/fonc.2021.661288

Figure 2.

Figure 2

Role of MIR4435-2HG inhibition on growth, metastasis, and epithelial–mesenchymal transition (EMT) of gastric carcinoma cells. (A) qRT-PCR was applied to test MIR4435-2HG after constructing si-MIR4435-2HG in SGC-7901 and MGC-803 cells. (B) qRT-PCR was applied to test MIR4435-2HG in cells transfected with si-MIR4435-2HG#1 in SGC-7901 and MGC-803 cells. (C) Cell Counting Kit-8 (CCK-8) test was applied to test the proliferation of gastric carcinoma cells transfected with si-MIR4435-2HG#1 in SGC-7901 and MGC-803 cells. (D, E) Transwell test was applied to test the invasion and migration of gastric carcinoma cells transfected with si-MIR4435-2HG#1 in SGC-7901 and MGC-803 cells. (F) Flow cytometry was applied to test the apoptosis of gastric carcinoma cells transfected with si-MIR4435-2HG#1 in SGC-7901 and MGC-803 cells. (G) Western blotting experiment was applied to test the changes of EMT protein in cells. (H) qRT-PCR was applied to test the mRNA changes of EMT markers in cells in SGC-7901 and MGC-803 cells. * indicates p < 0.05; ** indicates p < 0.01.